HESA Committee Report
If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.
Appendix B: List of Witnesses
The following table lists the witnesses who appeared before the committee at its meetings related to this report. Transcripts of all public meetings related to this report are available on the committee’s webpage for this study.
Committee Meeting No. 61 – HESA (44-1) – Tuesday, April 18, 2023
That the evidence heard by the committee in relation to its study of over-the-counter paediatric medication be taken into consideration by the committee in its study of children’s health.
Over-the-Counter Paediatric Medication/strong>
Organizations and Individuals |
Date |
Meeting |
Association québécoise des distributeurs en pharmacie Hugues Mousseau, Director General |
2022/11/15 |
42 |
Children's Healthcare Canada Emily Gruenwoldt, President and Chief Executive Officer |
2022/11/15 |
42 |
Critical Drugs Coalition Dr. Saad Ahmed, Physician |
2022/11/15 |
42 |
Department of Health Kim Godard, Acting Director General, Health Product Compliance Directorate, Regulatory Operations and Enforcement Branch Linsey Hollett, Director General, Health Product Compliance Directorate, Regulatory Operations and Enforcement Branch Stephen Lucas, Deputy Minister Dr. Supriya Sharma, Chief Medical Advisor and Senior Medical Advisor, Health Products and Food Branch Stefania Trombetti, Assistant Deputy Minister, Regulatory Operations and Enforcement Branch |
2022/11/15 |
42 |
Food, Health & Consumer Products of Canada Gerry Harrington, Senior Advisor |
2022/11/15 |
42 |